IBEX Ltd Dossier
|
SectorIndustrials IndustryProfessional Services Beta (adjusted)0.81 Intrinsic Value $50.31median of 6 methods · middle span $23-$133based on filings through 31 Mar 2026 Market Price $44.28Price as of 1 Oct 2026 Near fair valueIntrinsic value is 14% above the market price −50% · IV below pricenear fair value ±15%IV above price · +50% Data confidence Sign in to view data confidence Market Cap $588M Enterprise Value $556.2M Shares Outstanding 14.8M diluted Moat Rating Wide Next Earnings Date5 Nov 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary IBEX Ltd continues to separate itself from the traditional BPO market by delivering consistent double-digit revenue growth and robust operating leverage. The company's strategic pivot toward high-margin verticals (such as HealthTech and Retail & E-commerce) and its landmark partnership with Sierra to deploy agentic AI solutions position it well for the 'BPO 3.0' era. Despite these strong fundamentals, the stock remains attractively valued, trading like a low-growth legacy outsourcer rather than a high-performing digital CX leader. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$35.00 Mean target$37.50 High · most bullish analyst$40.00 Street targets sit below today's price; our intrinsic value sits above it. Different horizons, different questions. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $30.0010% AI deployments scale slower than expected, leading to near-term margin compression, while client concentration risks or further declines in the legacy telecommunications vertical flatten top-line growth. Base CaseCentral scenario $37.5060% Matches the consensus meanIBEX maintains its steady double-digit revenue growth trajectory, successfully integrates conversational AI to improve human agent productivity, and achieves its raised FY26 guidance. Bull CaseUpside scenario $40.0030% Rapid scaling of the Sierra AI partnership drives significant margin expansion and accelerates market share gains, while high-margin verticals like HealthTech continue to grow at >30% annually. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |